335 related articles for article (PubMed ID: 23972508)
21. Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.
Boyd KP; Gao L; Feng R; Beasley M; Messiaen L; Korf BR; Theos A
J Am Acad Dermatol; 2010 Sep; 63(3):440-7. PubMed ID: 20605257
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous Findings in Neurofibromatosis Type 1.
Ozarslan B; Russo T; Argenziano G; Santoro C; Piccolo V
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530415
[TBL] [Abstract][Full Text] [Related]
23. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic outcome in children with multiple café au lait spots.
Korf BR
Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
[TBL] [Abstract][Full Text] [Related]
26. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
[TBL] [Abstract][Full Text] [Related]
27. Ophthalmological manifestations in segmental neurofibromatosis type 1.
Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
[TBL] [Abstract][Full Text] [Related]
28. Multiple or familial café-au-lait spots is neurofibromatosis type 6: clarification of a diagnosis.
Madson JG
Dermatol Online J; 2012 May; 18(5):4. PubMed ID: 22630574
[TBL] [Abstract][Full Text] [Related]
29. Relationship between café-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study.
Fois A; Calistri L; Balestri P; Vivarelli R; Bartalini G; Mancini L; Berardi A; Vanni M
Eur J Pediatr; 1993 Jun; 152(6):500-4. PubMed ID: 8335018
[TBL] [Abstract][Full Text] [Related]
30. Anemic nevus in neurofibromatosis type 1.
Tadini G; Brena M; Pezzani L; Gelmetti C; Santagada F; Boldrini MP
Dermatology; 2013; 226(2):115-8. PubMed ID: 23713063
[TBL] [Abstract][Full Text] [Related]
31. The absence that makes the difference: choroidal abnormalities in Legius syndrome.
Tucci A; Saletti V; Menni F; Cesaretti C; Scuvera G; Esposito S; Melloni G; Esposito S; Milani D; Cereda C; Cigada M; Tresoldi L; Viola F; Natacci F
J Hum Genet; 2017 Nov; 62(11):1001-1004. PubMed ID: 28747691
[TBL] [Abstract][Full Text] [Related]
32. Nevus anemicus and RASopathies.
Bulteel C; Morren MA; De Haes P; Denayer E; Legius E; Brems H
JAAD Case Rep; 2018 May; 4(4):390-391. PubMed ID: 29693080
[No Abstract] [Full Text] [Related]
33. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
34. Café-au-lait macules and intertriginous freckling in piebaldism: clinical overlap with neurofibromatosis type 1 and Legius syndrome.
Stevens CA; Chiang PW; Messiaen LM
Am J Med Genet A; 2012 May; 158A(5):1195-9. PubMed ID: 22438235
[TBL] [Abstract][Full Text] [Related]
35. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
36. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.
DeBella K; Szudek J; Friedman JM
Pediatrics; 2000 Mar; 105(3 Pt 1):608-14. PubMed ID: 10699117
[TBL] [Abstract][Full Text] [Related]
37. Eye disorders in neurofibromatosis (NF1).
Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
[TBL] [Abstract][Full Text] [Related]
38. [Angiomatous and cerulodermic macules: early cutaneous signs of neurofibromatosis type I].
Vabres P; de Lonlay P; Amiel J; Lyonnet S; Munnich A; de Prost Y
Ann Dermatol Venereol; 1998 Sep; 125(9):593-4. PubMed ID: 9805547
[TBL] [Abstract][Full Text] [Related]
39. Case report: Gene mutation analysis and skin imaging of isolated café-au-lait macules.
Zhong Z; Yang T; Liu S; Wang S; Zhou S; Du S; Zheng L; Wang X; Wang H; Wang Y; Gao M
Front Genet; 2023; 14():1126555. PubMed ID: 37025448
[No Abstract] [Full Text] [Related]
40. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
